X
    X
    X
    X

    Locke Lord Team’s Representation of Zydus in Shire’s Appeal to Overturn Lialda Win Highlighted in IP Law360

    Articles

    Michael Gaertner, Hugh Balsam, James Peterka, David Abramowitz, Andy Miller, Wasim Bleibel, Timothy Peterson (all of Chicago) and Andrea Wayda (New York) represented Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited as Shire Development LLC sought to overturn the district court’s decision that Zydus’s generic version of Shire’s ulcerative colitis drug Lialda does not infringe Shire’s U.S. Patent No. 6,773,720.

    To read the complete article, click here (subscription may be required).

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.